The trial aims to establish clinical proof-of-concept in psoriasis and proof-of-mechanism for other CCR6- and Th17-associated autoimmune indicationsAllschwil, Switzerland - January 6, 2026 ...

Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering first-in-class therapeutics ...

Under normal conditions, cytokines aid in pathogen recognition and elimination while contributing to immune system ...

MPESB has released the Exam Calendar 2026 covering recruitment, entrance and eligibility tests scheduled from January to ...

Applications are invited for recruitment of various project based positions or jobs in Mizoram University in 2026. Mizoram University is inviting applications from eligible candidates for recruitment ...

Lucara Diamond Corp. ("Lucara" or the "Company") is pleased to announce the results of an updated technical report (the "Report") for the updated Feasibility Study ("FS" or "Study"), prepared in ...

Despite the unique ideological and political advantages of the “Aircraft Power Supply System” course, there are still some deep-seated problems that urgently need to be solved in the current teaching ...

BRIDGEWATER, N.J., United States and BENGALURU, Karnataka, India, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Biocon Biologics Ltd. (BBL), a fully ...

Lead candidate in the MLLT1/3 programme, DBT 3757, is a differentiated investigational molecule designed to treat Acute Myeloid LeukemiaAcquisition brings a new therapeutic mechanism to Amgen's ...

Novel immunotherapy combination regimen brings together two complementary therapies to improve outcomes for people living with multiple myeloma as early as second line1 ...

The trial aims to establish clinical proof-of-concept in psoriasis and proof-of-mechanism for other CCR6- and Th17-associated autoimmune indications Allschwil, Switzerland - January 6, 2026Idorsia ...

The calendar contains the list of tentative schedules for multiple examinations that the Board will conduct from February to ...